Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-02 22:56:19 - browse：855

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Bright Health sells Medicare Advantage business to Molina

WSS

How to convince healthy people to buy insurance

How to convince healthy people to buy insurance

Guidelines to prevent youth baseball injuries need more muscle

Trump demands the U.S. pay no more for drugs than other countries … again

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

All of Us, NIH's precision medicine initiative, gets a big boost

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Anesthesiologist group: stop taking Ozempic before surgery

Gene therapy’s promise and the high cost of hope

Alkermes shareholders re

Live blog: Hearing on CRISPR

Medicare proposal to cover medical devices draws a mixed reaction

After affirmative action ruling, medical educators look to 'holistic review'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

DIEP, the 'gold standard' of breast reconstruction, is under threat

The health care issue Democrats can’t solve: hospital reform

knowledge

Key Senate panel to consider PBM, drug pricing reform package

Peter Hotez and the public health issue of online harassment

Activists slam private health insurers over coverage restrictions

Novavax promises a turnaround & Lilly roils the obesity market

Life sciences investors close nearly $6 billion in new funds

Affirmative action in medical school literally saved lives

entertainment

hotspot

knowledge

Wikipedia